Efficacy of minimally invasive pectopexy with concomitant I‐stop‐mini sling for women with pelvic organ prolapse and overt stress urinary incontinence: A retrospective cohort study

Objective To compare the efficacy of minimally invasive pectopexy with I‐stop‐mini (MPI) and minimally invasive sacrocolpopexy with Obtryx (MSO). Methods Women with pelvic organ prolapse quantification (POP‐Q) stage III or more and overt stress urinary incontinence from May 2018 to May 2021 were inc...

Full description

Saved in:
Bibliographic Details
Published in:International journal of gynecology and obstetrics 2023-08, Vol.162 (2), p.552-561
Main Authors: Chao, Wei‐Ting, Liu, Chia‐Hao, Yang, Szu‐Ting, Chen, Yi‐Jen, Wang, Peng‐Hui, Horng, Huann‐Cheng
Format: Article
Language:English
Subjects:
I‐stop‐mini
minimally invasive
Obtryx
pectopexy
sacrocolpopexy
stress urinary incontinence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To compare the efficacy of minimally invasive pectopexy with I‐stop‐mini (MPI) and minimally invasive sacrocolpopexy with Obtryx (MSO). Methods Women with pelvic organ prolapse quantification (POP‐Q) stage III or more and overt stress urinary incontinence from May 2018 to May 2021 were included. Patients with meshes fixed on the cervix or vaginal vault and bilateral pectineal ligament with I‐stop‐mini were classified into the MPI group, while those fixed on the apex and sacral promontory with Obtryx were classified into the MSO group. The primary outcomes were 1‐year‐postoperative POP‐Q stage, patient‐reported urinary and prolapse outcomes (Urogenital Distress Inventory‐6, International Consultation on Incontinence Questionnaire‐Short Form, and Pelvic Organ Prolapse Distress Inventory‐6), 1‐h pad test, and sexual life quality (Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire). Secondary outcomes included operative data and adverse events. Results The efficacy of MPI was similar to that of MSO according to the primary outcomes. MPI had shorter operative times (133.4 ± 30.6 min versus 199.3 ± 20.9 min, P = 0.001) and lower incidence rate of abdominal pain (0% vs 20%, P = 0.02) and groin pain (8% vs 40%, P = 0.01) than MSO. Conclusions MPI showed similar efficacy to MSO, but demonstrated shorter operative times and lower incidence rates of abdominal and groin pain. Synopsis Efficacy of minimally invasive pectopexy with I‐stop‐mini was similar to that of sacrocolpopexy and Obtryx at the 1‐year follow up.
ISSN:0020-7292
1879-3479
DOI:10.1002/ijgo.14758